BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhu JZ, Hollis-Hansen K, Wan XY, Fei SJ, Pang XL, Meng FD, Yu CH, Li YM. Clinical guidelines of non-alcoholic fatty liver disease: A systematic review. World J Gastroenterol 2016; 22(36): 8226-8233 [PMID: 27688665 DOI: 10.3748/wjg.v22.i36.8226]
URL: https://www.wjgnet.com/1007-9327/full/v22/i36/8226.htm
Number Citing Articles
1
Claudio Tana, Cosima Schiavone, Andrea Ticinesi, Fulvio Lauretani, Antonio Nouvenne, Christoph Frank Dietrich, Tiziana Meschi. Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspectiveInternational Journal of Immunopathology and Pharmacology 2018; 32 doi: 10.1177/2058738418781373
2
Anja Baumann, Annette Brandt, Ina Bergheim. Fructose, a trigger of metabolic diseases?—a narrative reviewExploration of Digestive Diseases 2022; : 51 doi: 10.37349/edd.2022.00005
3
Rocío Valenzuela-Narváez, Daniel Valenzuela-Narváez. Interaction of periodontal clinical indicators in metabolic syndrome and nonalcoholic fatty liver disease: Implications for preventive interventionsThe Saudi Dental Journal 2024; 36(7): 1015 doi: 10.1016/j.sdentj.2024.04.013
4
Naoki Sakane, Kazuhiko Kotani, Akiko Suganuma, Kaoru Takahashi, Juichi Sato, Sadao Suzuki, Kazuo Izumi, Masayuki Kato, Mitsuhiko Noda, Shinsuke Nirengi, Hideshi Kuzuya. Effects of obesity, metabolic syndrome, and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J-DOIT1Journal of Occupational Health 2020; 62(1) doi: 10.1002/1348-9585.12109
5
Vahid Sheikhi, Zahra Heidari. Low Vitamin D Level was Associated with Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes MellitusShiraz E-Medical Journal 2021; 23(3) doi: 10.5812/semj.118125
6
Annette Brandt, Cheng Jin, Katja Nolte, Cathrin Sellmann, Anna Engstler, Ina Bergheim. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic TreatmentNutrients 2017; 9(9): 1013 doi: 10.3390/nu9091013
7
Andressa OLIVEIRA, Sabrina Alves FERNANDES, Randhall Bruce CARTERI, Cristiane Valle TOVO. EVALUATION OF REST ENERGY EXPENDITURE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASEArquivos de Gastroenterologia 2021; 58(2): 157 doi: 10.1590/s0004-2803.202100000-27
8
Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca Valenti, Guido Ligabue, Susanna Schianchi, Marco Massari, Nicoletta Riva, Elisabetta Froio, Elena Tagliavini, Pierpaolo Pattacini, Paolo Giorgi Rossi. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective studyDiabetes Research and Clinical Practice 2021; 177: 108882 doi: 10.1016/j.diabres.2021.108882
9
Kenneth W. Chow, Pragyat Futela, Aryan Saharan, Sammy Saab. Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2023; 13(5): 783 doi: 10.1016/j.jceh.2023.01.016
10
Anja Baumann, Cheng Jin, Annette Brandt, Cathrin Sellmann, Anika Nier, Markus Burkard, Sascha Venturelli, Ina Bergheim. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic SteatohepatitisNutrients 2020; 12(4): 951 doi: 10.3390/nu12040951
11
Alexandra Jichitu, Simona Bungau, Ana Maria Alexandra Stanescu, Cosmin Mihai Vesa, Mirela Marioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbasa, Camelia Cristina Diaconu. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic ManagementDiagnostics 2021; 11(4): 689 doi: 10.3390/diagnostics11040689
12
Huanqiu Wang, Ruyu Sun, Sisi Yang, Xueqing Ma, Chengbo Yu. Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic reviewFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.934989
13
Yuqiu Fu, Deyue Zang, Baiyou Lin, Qiming He, Yujie Xie, Baoliang Zhang, Yao Liu, Yi Jin, Yonghong He, Tian Guan. A Deep Learning Method Enables Quantitative and Automatic Measurement of Rat Liver Histology in NAFLDInternational Journal of Imaging Systems and Technology 2024; 34(4) doi: 10.1002/ima.23123
14
Mohsen Arabi, Raheleh Alimoradzadeh, Alireza Makian, Seyed Javad Shariat Nabavi, Farshad Divsalar, Mitra Kazemi Jahromi. Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini ReviewJournal of Health Reports and Technology 2022; 8(3) doi: 10.5812/jhrt-119454
15
Muhammad Ijaz Ahmad, Xiaoyou Zou, Muhammad Umair Ijaz, Muzahir Hussain, Congcong Liu, Xinglian Xu, Guanghong Zhou, Chunbao Li. Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient MiceJournal of Agricultural and Food Chemistry 2019; 67(32): 8794 doi: 10.1021/acs.jafc.9b03136
16
Alexa M. Giammarino, He Qiu, Kishen Bulsara, Sabrina Khan, Yu Jiang, Ben L. Da, David E. Bernstein, Sanjaya K. Satapathy. Community Socioeconomic Deprivation Predicts Nonalcoholic SteatohepatitisHepatology Communications 2022; 6(3): 550 doi: 10.1002/hep4.1831
17
Mohammed Amin Mohammed, Nesreen Moustafa Omar, Soad Amin Mohammed, Ahmed Mohammed Amin, Doaa Farouk Gad. FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian PatientsPakistan Journal of Biological Sciences 2019; 22(10): 457 doi: 10.3923/pjbs.2019.457.466
18
Carolina M. Perdomo, Nuria Garcia-Fernandez, Javier Escalada. Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?Journal of Clinical Medicine 2021; 10(9): 2040 doi: 10.3390/jcm10092040
19
Kay Craven, Donna Clement, Caroline T. Brewster, Jamie Messenger, Kathryn M. Kolasa. Non-Alcoholic Fatty Liver Disease (NAFLD) and NutritionNutrition Today 2021; 56(6): 296 doi: 10.1097/NT.0000000000000514
20
Leila Zarei, Negin Farhad, Ata Abbasi. All-Trans Retinoic Acid (atRA) effectively improves liver steatosis in a rabbit model of high fat induced liver steatosisArchives of Physiology and Biochemistry 2022; 128(4): 1010 doi: 10.1080/13813455.2020.1743725
21
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2020; 21(16): 5888 doi: 10.3390/ijms21165888
22
Felipe Galvão Batista Chaves, Glauco Ferreira de Oliveira, João Paulo Ribeiro, João Victor Serafim, Luiz Felipe Medeiros Cordeiro, Matheus Alves Alvares, Marcelo Trindade Cecchi, Murilo Cordeiro Vasquez, Thaísy Bianka Dorta de Souza, Vera Esteves Vagnozzi Rullo. THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEWRevista Paulista de Pediatria 2021; 39 doi: 10.1590/1984-0462/2021/39/2019226
23
I.M. Hrytsai, A.Ye. Husieva, V.I. Medved. Obstetric cholestasis: modern recommendations for diagnosis, treatment, management of pregnancy and childbirth Reproductive health of woman 2022; (4): 11 doi: 10.30841/2708-8731.4.2022.262758
24
Shreya C. Pal, Nahum Méndez-Sánchez. Screening for MAFLD: who, when and how?Therapeutic Advances in Endocrinology and Metabolism 2023; 14 doi: 10.1177/20420188221145650
25
Fan Li, Gang Sun, Zikai Wang, Wenming Wu, He Guo, Lihua Peng, Lili Wu, Xu Guo, Yunsheng Yang. Characteristics of fecal microbiota in non-alcoholic fatty liver disease patientsScience China Life Sciences 2018; 61(7): 770 doi: 10.1007/s11427-017-9303-9
26
Anika Nier, Anna Janina Engstler, Ina Barbara Maier, Ina Bergheim, Pavel Strnad. Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in childrenPLOS ONE 2017; 12(9): e0183282 doi: 10.1371/journal.pone.0183282
27
Paul J. Pockros, Michael Fuchs, Bradley Freilich, Eugene Schiff, Anita Kohli, Eric J. Lawitz, Paul A. Hellstern, Janet Owens‐Grillo, Courtney Van Biene, Reshma Shringarpure, Leigh MacConell, David Shapiro, David E. Cohen. CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patientsLiver International 2019; 39(11): 2082 doi: 10.1111/liv.14209
28
Mengqiu Wei, Jun Liu, Hailin Pan, Ziting Zhou, Kai Guo. Plasma Leukocyte Cell-Derived Chemotaxin 2 (LECT2) as a Risk Factor of Coronary Artery Disease: A Cross-Sectional StudyAngiology 2022; 73(3): 265 doi: 10.1177/00033197211028023
29
Natalia Zhelezniakova, Oleg Babak, Tetiana Aleksandrova. MODERN METHODS OF DIAGNOSIS AND SCREENING OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS STAGES: reviewInter Collegas 2022; 8(4): 226 doi: 10.35339/ic.8.4.226-231